UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 589

Sortiert nach

Gene networks activated by specific patterns of action potentials in dorsal root ganglia neurons

Scientific reports, 2017-03, Vol.7 (1), p.43765-43765, Article 43765

2017

Volltextzugriff (PDF)

Checkpoint inhibitors: Better outcomes among advanced cutaneous head and neck melanoma patients

PloS one, 2020-04, Vol.15 (4), p.e0231038-e0231038

2020

Volltextzugriff (PDF)

Radioresistant tumours: From identification to targeting

Cancer radiothérapie, 2020-10, Vol.24 (6-7), p.699-705

2020

Volltextzugriff (PDF)

Optimization of Detection of Gadodiamide Brain Retention in Rats Using Quantitative T2 Mapping and Intraperitoneal Administration

Journal of magnetic resonance imaging, 2022-11, Vol.56 (5), p.1499-1504

2022

Volltextzugriff (PDF)

RadioTransNet, the French network for preclinical research in oncological radiotherapy

Cancer radiothérapie, 2019-10, Vol.23 (6-7), p.609-616

2019

Volltextzugriff (PDF)

Intratumoral immune-biomarkers and mismatch repair status in leiyomyosarcoma -potential predictive markers for adjuvant treatment: a pilot study

Oncotarget, 2018-07, Vol.9 (56), p.30847-30854

2018

Volltextzugriff (PDF)

The role of immune checkpoint receptors in the malignant phenotype of cutaneous T cell lymphoma

Immunologic research, 2022-12, Vol.70 (6), p.793-799

2022

Volltextzugriff (PDF)

Defective skeletal muscle growth in lamin A/C-deficient mice is rescued by loss of Lap2[alpha]

Human molecular genetics, 2013-07, Vol.22 (14), p.2852-2869

2013

Volltextzugriff (PDF)

Author Correction: ChIP-seq of plasma cell-free nucleosomes identifies gene expression programs of the cells of origin

Nature biotechnology, 2021-05, Vol.39 (5), p.642-642

2021

Volltextzugriff (PDF)

Author Correction: ChIP-seq of plasma cell-free nucleosomes identifies gene expression programs of the cells of origin

Nature biotechnology, 2021-05, Vol.39 (5), p.642-642

2021

Volltextzugriff (PDF)

Optimizing antiangiogenic strategies: combining with radiotherapy

Targeted oncology, 2008, Vol.3 (1), p.51-56

Cohen-Jonathan Moyal, E.

2008

Volltextzugriff (PDF)

SP-0579 COMBINATION OF TARGETED DRUGS WITH RADIOATHERAPY IN GLIOBASTOMA = FROM MECHANISMS TO THERAPY

Radiotherapy and oncology, 2012-05, Vol.103, p.S232-S232

Moyal-Cohen-Jonathan, E

2012

Volltextzugriff (PDF)

Glioblastoma heterogeneity and cancer stem-like cells detection with advanced MRI in the non contrast enhancing tumor: time to personalized surgery and therapeutic paradigm shift?

Brain & spine, 2021, Vol.1, p.100512, Article 100512

2021

Volltextzugriff (PDF)

379 ANGIOGENIC INHIBITORS AND RADIOTHERAPY

Radiotherapy and oncology, 2012-03, Vol.102, p.S193-S193

Cohen Jonathan Moyal, E

2012

Volltextzugriff (PDF)

BLOOD VESSEL INVASION PREDICTED POOR PROGNOSIS IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CARCINOMA TREATED WITH RADIO AND CHEMO-THERAPY

Radiotherapy and oncology, 2009-08, Vol.92, p.S141-S141

2009

Volltextzugriff (PDF)

Early Differentiation of Pseudoprogression for Recurrent Glioblastoma in STERIMGLI Trial Using Multimodal MRI Radiomics Signature

International journal of radiation oncology, biology, physics, 2022-11, Vol.114 (3), p.e78

2022

Volltextzugriff (PDF)

SP-0363: Predictive value of MR spectroscopic imaging for relapse site in GBM and integration in a dose-painting trial

Radiotherapy and oncology, 2015-04, Vol.115, p.S175-S176

2015

Volltextzugriff (PDF)

333 oral GLIOBLASTOMA DOSE PAINTING WITH IMRT SIMULTANEOUS INTEGRATED BOOST GUIDED BY MR SPECTROSCOPY

Radiotherapy and oncology, 2011, Vol.99, p.S133-S133

2011

Volltextzugriff (PDF)

61 poster: Integration of 3D Magnetic Resonance Spectroscopy Maps into Treatment Planning of Glioblastoma

Radiotherapy and oncology, 2010-03, Vol.94, p.S24-S25

2010

Volltextzugriff (PDF)

PO-1078 Ionizing radiations sustain Glioblastoma cell dedifferentiation to a stem phenotype through Survivin

Radiotherapy and oncology, 2015-04, Vol.115, p.S582-S582

2015

Volltextzugriff (PDF)

OC-0615: Voxel-based perfusion normalisation in GBM patients included in a phase I-II trial of RT/Tipifarnib combination

Radiotherapy and oncology, 2015-04, Vol.115, p.S297-S298

2015

Volltextzugriff (PDF)

SP-0598: Cilengitide in continuous infusion with radio-chemotherapy in stage III NSCLC: A phase I clinical trial

Radiotherapy and oncology, 2015-04, Vol.115, p.S291-S291

2015

Volltextzugriff (PDF)

P01.09 INHIBITION OF FGFR1 SENSITIZES HUMAN GLIOBLASTOMA TO RADIOTHERAPY

Neuro-oncology (Charlottesville, Va.), 2014-09, Vol.16 (suppl 2), p.ii28-ii28

2014

Volltextzugriff (PDF)

OC-34: Integrin-Linked-Kinase (ILK) Controls Glioma Cell Response to Ionizing Radiation Through HIF-1Alpha

Radiotherapy and oncology, 2012-09, Vol.104, p.32-32

2012

Volltextzugriff (PDF)

Optimisation de la radiothérapie des gliomes: espoirs et voies de recherche pour les années à venir

Revue neurologique (Paris), 2011, Vol.167 (10)

COHEN-JONATHAN MOYAL, E

2011

Volltextzugriff (PDF)

1 – 25 von 589

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(469)
Mit Volltextzugriff
(520)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(185)
Life Sciences & Biomedicine
(118)
Physical Sciences
(53)
Technology
(26)
Social Sciences
(24)
Neurosciences & Neurology
(23)
Hematology, Oncology And Palliative Medicine
(22)
Internal Medicine
(22)
Infectious Disease
(21)
Astronomy & Astrophysics
(19)
Biological And Medical Sciences
(19)
Physics
(19)
Environmental Sciences & Ecology
(17)
Oncology
(17)
Pediatrics
(17)
Ecology
(16)
Medical Sciences
(16)
Patients
(16)
Medicine
(15)
Neurosciences
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Gene networks activated by specific patterns of action potentials in dorsal root ganglia neurons

Checkpoint inhibitors: Better outcomes among advanced cutaneous head and neck melanoma patients

Radioresistant tumours: From identification to targeting

Optimization of Detection of Gadodiamide Brain Retention in Rats Using Quantitative T2 Mapping and Intraperitoneal Administration

RadioTransNet, the French network for preclinical research in oncological radiotherapy

Intratumoral immune-biomarkers and mismatch repair status in leiyomyosarcoma -potential predictive markers for adjuvant treatment: a pilot study

The role of immune checkpoint receptors in the malignant phenotype of cutaneous T cell lymphoma

Defective skeletal muscle growth in lamin A/C-deficient mice is rescued by loss of Lap2[alpha]

Author Correction: ChIP-seq of plasma cell-free nucleosomes identifies gene expression programs of the cells of origin

Author Correction: ChIP-seq of plasma cell-free nucleosomes identifies gene expression programs of the cells of origin

Optimizing antiangiogenic strategies: combining with radiotherapy

SP-0579 COMBINATION OF TARGETED DRUGS WITH RADIOATHERAPY IN GLIOBASTOMA = FROM MECHANISMS TO THERAPY

Glioblastoma heterogeneity and cancer stem-like cells detection with advanced MRI in the non contrast enhancing tumor: time to personalized surgery and therapeutic paradigm shift?

379 ANGIOGENIC INHIBITORS AND RADIOTHERAPY

BLOOD VESSEL INVASION PREDICTED POOR PROGNOSIS IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CARCINOMA TREATED WITH RADIO AND CHEMO-THERAPY

Early Differentiation of Pseudoprogression for Recurrent Glioblastoma in STERIMGLI Trial Using Multimodal MRI Radiomics Signature

SP-0363: Predictive value of MR spectroscopic imaging for relapse site in GBM and integration in a dose-painting trial

333 oral GLIOBLASTOMA DOSE PAINTING WITH IMRT SIMULTANEOUS INTEGRATED BOOST GUIDED BY MR SPECTROSCOPY

61 poster: Integration of 3D Magnetic Resonance Spectroscopy Maps into Treatment Planning of Glioblastoma

PO-1078 Ionizing radiations sustain Glioblastoma cell dedifferentiation to a stem phenotype through Survivin

OC-0615: Voxel-based perfusion normalisation in GBM patients included in a phase I-II trial of RT/Tipifarnib combination

SP-0598: Cilengitide in continuous infusion with radio-chemotherapy in stage III NSCLC: A phase I clinical trial

P01.09 INHIBITION OF FGFR1 SENSITIZES HUMAN GLIOBLASTOMA TO RADIOTHERAPY

OC-34: Integrin-Linked-Kinase (ILK) Controls Glioma Cell Response to Ionizing Radiation Through HIF-1Alpha

Optimisation de la radiothérapie des gliomes: espoirs et voies de recherche pour les années à venir

Aktive Filter

Suchergebnisse filtern